Medicare Enrolled
Dr. Charles Kilo, MD
Endocrinology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kilo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kilo? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kilo
Dr. Charles Kilo is an endocrinology in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kilo performed 23,529 Medicare services across 14,576 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kilo received a total of $78,123 from 66 pharmaceutical and/or device companies across 1639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kilo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in FL$ $78,123 industry payments
Medicare Practice Summary
Medicare Utilization ↗23,529
Medicare services
Top 3% in FL for endocrinology
14,576
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,238 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,162 | $90 | $264 |
| Blood draw (venipuncture) | 1,449 | $8 | $17 |
| Vitamin B-12 level test | 1,332 | $15 | $30 |
| Lipid panel (cholesterol and triglycerides) | 1,315 | $13 | $27 |
| Glutamyltransferase (liver enzyme) level | 1,291 | $7 | $14 |
| Comprehensive metabolic blood panel | 1,257 | $10 | $21 |
| Sed rate test (inflammation marker) | 1,244 | $3 | $5 |
| Vitamin D level test | 1,234 | $29 | $59 |
| Magnesium level test | 1,208 | $7 | $13 |
| Creatine kinase (cardiac enzyme) level, total | 1,178 | $6 | $13 |
| Hemoglobin A1c test (diabetes monitoring) | 1,074 | $10 | $19 |
| Denosumab injection (Prolia/Xgeva) | 901 | $18 | $47 |
| Thyroid stimulating hormone (TSH) test | 796 | $16 | $34 |
| Complete blood count (CBC) with differential | 751 | $8 | $16 |
| Annual wellness visit, follow-up | 651 | $131 | $267 |
| Annual depression screening | 631 | $18 | $38 |
| Free thyroxine (T4) test | 558 | $9 | $18 |
| Electrocardiogram (EKG), 12-lead | 375 | $11 | $30 |
| Prostate cancer screening; prostate specific antigen test (psa) | 316 | $19 | $39 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 296 | $18 | $36 |
| Drug injection, under skin or into muscle | 253 | $10 | $30 |
| Injection, ketorolac tromethamine, per 15 mg | 236 | $0 | $1 |
| Flu vaccine administration | 211 | $31 | $64 |
| Flu vaccine, high-dose | 208 | $72 | $144 |
| Automated urinalysis | 171 | $2 | $4 |
| Urine microalbumin test (kidney screening) | 169 | $6 | $12 |
| Creatinine test (kidney function) | 169 | $5 | $10 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 166 | $281 | $576 |
| Pneumonia vaccine administration | 165 | $32 | $64 |
| Iron level test | 154 | $6 | $13 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 122 | $1 | $3 |
| Thyroid hormone, t3 measurement, free | 112 | $17 | $34 |
| Uric acid level test | 112 | $4 | $9 |
| Urine culture, bacterial colony count | 110 | $8 | $16 |
| Ferritin level test (iron stores) | 106 | $13 | $27 |
| Iron binding capacity test | 104 | $9 | $17 |
| Office visit, established patient (20-29 min) | 99 | $56 | $187 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 98 | $4 | $11 |
| PSA test (prostate cancer screening) | 89 | $18 | $37 |
| Urinalysis with microscopic exam | 87 | $3 | $6 |
| Transitional care management services for problem of high complexity | 77 | $215 | $570 |
| New patient office visit (45-59 min) | 76 | $87 | $347 |
| Removal of impacted ear wax | 54 | $36 | $101 |
| Urinalysis, manual | 53 | $3 | $7 |
| Office visit, established patient, complex (40-54 min) | 37 | $141 | $370 |
| Antibiotic sensitivity test | 36 | $8 | $17 |
| Bacterial culture, aerobic | 35 | $8 | $16 |
| Testosterone (hormone) level, total | 28 | $25 | $52 |
| C-reactive protein test (inflammation marker) | 26 | $5 | $10 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 22 | $168 | $343 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 20 | $168 | $343 |
| Amylase (enzyme) level | 19 | $6 | $13 |
| Lipase (fat enzyme) level | 19 | $7 | $14 |
| Transitional care management services for problem of at least moderate complexity | 19 | $161 | $420 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 18 | $9 | $30 |
| Blood glucose (sugar) test performed by hand-held instrument | 16 | $3 | $7 |
| Phosphate level test | 14 | $5 | $9 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$78,123
Total received (2018-2024)
Avg $11,160/year across 7 years
Top 8% in FL for endocrinology
66
Companies
1,639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51,788 (66.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,886 (30.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,449 (3.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,747
2023$3,557
2022$3,366
2021$4,109
2020$11,400
2019$21,801
2018$31,142
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$52,159
Novo Nordisk Inc
$3,595
MannKind Corporation
$2,781
SANOFI-AVENTIS U.S. LLC
$2,246
Lilly USA, LLC
$1,828
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,657
AstraZeneca Pharmaceuticals LP
$1,592
Amgen Inc.
$1,439
Merck Sharp & Dohme Corporation
$852
Currax Pharmaceuticals LLC
$809
PFIZER INC.
$699
Abbott Laboratories
$676
Amarin Pharma Inc.
$671
Xeris Pharmaceuticals, Inc.
$559
Novartis Pharmaceuticals Corporation
$550
Bayer Healthcare Pharmaceuticals Inc.
$517
GlaxoSmithKline, LLC.
$515
Bayer HealthCare Pharmaceuticals Inc.
$412
Insulet Corporation
$324
Astellas Pharma US Inc
$272
Dexcom, Inc.
$266
Corcept Therapeutics
$227
Zealand Pharma US, Inc.
$217
Valeritas, Inc.
$208
Exact Sciences Corporation
$206
Esperion Therapeutics, Inc.
$196
Takeda Pharmaceuticals U.S.A., Inc.
$193
Regeneron Healthcare Solutions, Inc.
$187
Tandem Diabetes Care, Inc.
$163
IBSA Pharma Inc.
$162
ABBVIE INC.
$139
Mannkind Corporation
$129
Nevro Corp.
$118
Kowa Pharmaceuticals America, Inc.
$117
Merck Sharp & Dohme LLC
$104
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$101
Azurity Pharmaceuticals, Inc.
$91
Companion Medical, Inc.
$84
Phathom Pharmaceuticals, Inc.
$80
ARBOR PHARMACEUTICALS, INC.
$75
Paratek Pharmaceuticals, Inc.
$72
DEXCOM, INC.
$68
Radius Health, Inc.
$63
Embecta Corp.
$56
Ironwood Pharmaceuticals, Inc
$51
Biohaven Pharmaceuticals, Inc.
$47
Horizon Therapeutics plc
$45
Allergan, Inc.
$45
ABIOMED
$41
Sunovion Pharmaceuticals Inc.
$41
Biohaven Pharmaceutical Holding Company Ltd.
$37
Medtronic, Inc.
$34
SANOFI PASTEUR INC.
$34
Arbor Pharmaceuticals, Inc.
$31
CeQur Corporation
$28
Janssen Scientific Affairs, LLC
$27
BETA BIONICS, INC.
$24
Allergan Inc.
$23
E.R. Squibb & Sons, L.L.C.
$23
Axonics, Inc.
$20
Sumitomo Pharma America, Inc.
$18
LIFESCAN, INC.
$18
OptiNose US, Inc.
$17
Antares Pharma, Inc.
$17
EISAI INC.
$17
Almatica Pharma LLC
$14
Top 3 companies account for 74.9% of total payments
Associated products mentioned in payments ›
AFREZZA · ANORO · ARCTIC FRONT ADVANCE · AREXVY · Aduhelm · Aimovig · Axonics · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BELSOMRA · BEXSERO · BREZTRI · BYSTOLIC · CHANTIX · CONTRAVE · CeQur Simplicity · Cologuard Collection Kit · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DUEXIS · DUZALLO · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GEMTESA · GRALISE · GVOKE HYPOPEN · GVOKE PFS · HORIZANT · Horizant · INVOKANA · Impella · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LIVALO · LOKELMA · Licart · Livalo · MOUNJARO · MYRBETRIQ · Minimed 630G · NEXLETOL · NURTEC ODT · NUZYRA · ONZETRA XSAIL · OTREXUP · Omnia · Omnipod · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Proclaim IPG · Prolia · QULIPTA · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STEGLUJAN · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Senza · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xhance · ZEGALOGUE · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for endocrinology in FL.
Equivalent to $332 per 100 Medicare services performed
Geographic Context
Endocrinologys within 10 mi
18
Per 100K population
4.6
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kilo is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (speaking/promotional, top 8%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kilo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kilo performed 2,162 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kilo receive payments from pharmaceutical companies?
Yes. Dr. Kilo received a total of $78,123 from 66 companies across 1,639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kilo's costs compare to other endocrinologys in Naples?
Dr. Kilo's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kilo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in Naples
Browse endocrinologys in Naples ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in FL
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in FL
Which FL endocrinologys receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
MannKind Corporation Payments to Doctors
See all physicians who received payments from MannKind Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology